← Open Payments lookup

EZINWANYI MARK: Open Payments

NPI 1780374900 · RIVERSIDE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,008 in 37 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,008

Food & beverage: $1,008
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.10$169
Janssen Pharmaceuticals, Inc5$169
Teva Pharmaceuticals USA, Inc.7$149
Alkermes, Inc.2$148
Vanda Pharmaceuticals Inc.1$115
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$104
ABBVIE INC.3$64
Neurocrine BioSciences, Inc.2$54
Lundbeck LLC1$22
Takeda Pharmaceuticals U.S.A., Inc.1$14

Products named: INVEGA SUSTENNA, AUSTEDO XR, REXULTI, LYBALVI, FANAPT, CAPLYTA, VRAYLAR, ABILIFY ASIMTUFII.

Industry payments across CA — which companies pay providers there.